Society of Cutaneous Oncology Society of Cutaneous Oncology
  • Journal
  • Journal Club
  • Research Forum
  • Community Highlights
  • About
    • About SoCO
    • Our Philosophy
    • History
  • Join Our Community
The story of SoCO

From one clinic to a community.

The Society of Cutaneous Oncology began as a local multidisciplinary academic meeting in Boston. An unexpected move online widened the circle, and over time the group evolved into a broader scientific community built around critical discussion, collaborative research, and shared inquiry.

About SoCO Community Highlights

Society of Cutaneous Oncology logo

A history shaped by conversation

The format has changed—from an in-person conference room, to Zoom, to a multi-institutional scientific community—but the central idea has remained remarkably consistent: bring people together, examine the evidence carefully, and make the discussion useful.

2019
The local beginning
2020
The move online
2023
SoCO takes shape
2025+
A broader community
April 2, 2019

The first meeting

The group began as an in-person multidisciplinary academic program bringing together clinicians and investigators from Massachusetts General Hospital and Mass Eye and Ear around the management of non-melanoma skin cancers.

The opening Journal Club established the model that would continue to define the group: start with a clinically important paper, then interrogate what the evidence does—and does not—support.

First Journal Club

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial

Porceddu SV et al. Journal of Clinical Oncology. 2018;36:1275–1283.
March 3, 2020

The last in-person meeting

What had started as a recurring face-to-face academic meeting held its final in-person session just before the COVID-19 pandemic disrupted clinical, academic, and professional life worldwide.

A turning point

The interruption changed the format—and ultimately the reach.

On March 11, 2020, the World Health Organization characterized COVID-19 as a pandemic. The move away from in-person meetings was initially a necessity. It soon became an opportunity: geography no longer had to define who could join the conversation.

May 5, 2020

The group returns—online

Two months after the final in-person meeting, the program restarted on Zoom. The virtual format made it possible to invite colleagues beyond Boston and began the transition from a local institutional meeting toward a distributed academic community.

First online Journal Club

Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial

Topalian SL et al. Journal of Clinical Oncology. 2020;38:2476–2487.
November 8, 2022

The Journal of Cutaneous Oncology begins publishing

As the academic community grew, its scientific conversations gained a durable home. The Journal of Cutaneous Oncology (JoCO) began publishing as an open-access journal dedicated to skin cancer, evidence interpretation, scientific perspective, and thoughtful discussion.

The Journal emerged during the transition from the earlier Cutaneous Oncology Interest Group (COIG) toward what would soon become the Society of Cutaneous Oncology.

First JoCO publication

Neoadjuvant ICI for Resectable CSCC

Miller DM, Patel VA, Cohen JV, Garmen K, Shalhout SZ. Journal of Cutaneous Oncology. 2022;1(1). Published November 8, 2022.
March 6, 2023

The Society of Cutaneous Oncology

The expanding community was formally reintroduced as the Society of Cutaneous Oncology (SoCO). The new name reflected what the group had become: multidisciplinary, multi-institutional, and centered on the broader field of cutaneous oncology rather than any single institution or disease.

First Journal Club as SoCO

Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients

Allen NC et al. New England Journal of Medicine. 2023;388:804–812.
March 31, 2023

The first Research Forum

SoCO added a second kind of scientific conversation. Rather than beginning with a published paper, the Research Forum created a place to discuss ideas still in development—study concepts, methods, unanswered questions, and opportunities for collaboration.

Inaugural Research Forum
ICARUS
The first Research Forum focused on the ICARUS research program and established a venue for work in progress and collaborative study development.
April 10, 2025

The first joint academic–industry scientific session

SoCO held its first collaborative academic–industry meeting with Bristol Myers Squibb. The format extended the same principles used in Journal Club—open scientific discussion, careful evidence interpretation, and constructive critique—to a session that included both academic and industry participants.

Discussion focus

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study

Bhatia S et al. Journal of Clinical Oncology. 2025;43:1137–1147. CheckMate 358.

The next chapter is being written in public.

Today, SoCO brings together Journal Club, Research Forum, collaborative scientific projects, and the Journal of Cutaneous Oncology. What began as a local meeting now has both a living scientific community and a durable publishing platform. Its structure remains intentionally lightweight: the community grows through participation, and the scientific record grows through the meetings, methods, discussions, publications, and collaborations that follow.

Explore the community → Journal Club → Research Forum → Journal of Cutaneous Oncology →

Historical meeting dates reflect the Society’s internal program record. Publication details are linked to the original articles. COVID-19 pandemic context reflects the World Health Organization’s March 11, 2020 declaration.

© Society of Cutaneous Oncology

 
  • Journal of Cutaneous Oncology

  • SoCO Journal Club

  • Community Highlights

  • History